VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease.
about
State of the art: von Willebrand disease.Complex changes in von Willebrand factor-associated parameters are acquired during uncomplicated pregnancy.Laboratory aspects of von Willebrand disease: test repertoire and options for activity assays and genetic analysis.von Willebrand Factor Propeptide: A Potential Disease Biomarker Not Affected by ABO Blood Groups.Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease.von Willebrand factor propeptide: biology and clinical utilityA Laboratory Phenotype/Genotype Correlation of 1167 French Patients From 670 Families With von Willebrand Disease: A New Epidemiologic Picture.Markers of vascular perturbation correlate with airway structural change in asthma.Clearance of von Willebrand factor.Developments in the diagnostic procedures for von Willebrand disease.Current and emerging approaches for assessing von Willebrand disease in 2016.Diagnosing von Willebrand disease: genetic analysis.N-linked glycan truncation causes enhanced clearance of plasma-derived von Willebrand factor.Identification and characterization of the elusive mutation causing the historical von Willebrand Disease type IIC Miami.Genome-wide studies of von Willebrand factor propeptide identify loci contributing to variation in propeptide levels and von Willebrand factor clearance.Shear stress-independent binding of von Willebrand factor-type 2B mutants p.R1306Q & p.V1316M to LRP1 explains their increased clearance.Von Willebrand's disease: case report and review of literature.Diurnal variation of von Willebrand factor in plasma: the Bispebjerg study of diurnal variations.Can you grow out of von Willebrand disease?Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels.Macrophage scavenger-receptor SR-AI contributes to the clearance of von Willebrand factor.Identification and characterisation of mutations associated with von Willebrand disease in a Turkish patient cohort.No evidence for a direct effect of von Willebrand factor's ABH blood group antigens on von Willebrand factor clearance.FVIII/VWF ratio is not a reliable predictor of VWD in children.Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms.Comorbidities associated with higher von Willebrand factor (VWF) levels may explain the age-related increase of VWF in von Willebrand disease.Storage and secretion of naturally occurring von Willebrand factor A domain variants
P2860
Q30249030-91AF4AD3-436C-454F-B320-188D51AF8A65Q34542190-B36169F1-DA90-4257-8946-BEE02F85536AQ34750409-BE60E627-654C-4B38-A45C-548091F3631BQ35994251-7D703F2C-4F7A-4555-9C8C-021ED07583EEQ36105561-681B7E52-DABE-4139-B979-ECED2E5F5410Q36143225-F800A568-FF3D-4C0B-A9C6-DE5A1965C296Q36822738-096FB295-2BB6-44FA-A22D-3435AFDD402CQ37187005-CED01FC4-9FB7-4F67-9388-88EA35A78E3AQ38117738-2BEA52C2-BBCE-48BA-8475-6CD362596D15Q38682256-33381CCA-4E6B-4ED0-B656-B1C3E5597AB0Q38900004-D61B46FF-D79C-44C9-9F33-399A040DB8C6Q39027896-D958AA16-DEB6-4249-8FAC-69AD9208385AQ39299024-EC204571-DFA4-46C3-8452-56B2B69F33C7Q39655365-6ED180F3-8406-4A85-A582-455055DA6AA8Q41174649-668B48FD-CF5F-4B64-AE60-E570C4F13DFCQ41330193-EAAE8AD8-4D2B-4D2C-BE15-9147B2A59A0BQ41495178-3AC8428E-8BDB-4146-BC1A-526204AB3899Q44812694-1DCB07DD-7DE8-4136-911D-96C24A73C10AQ45874634-B92E0316-C836-455C-8646-96A0C04756C9Q47793791-F1E83528-B806-45D3-B57C-C046D2CA089FQ50078393-4BBD3C15-B6C8-42F8-B5B7-23DD6C23F701Q50965737-BABC624E-F68D-4DEB-B193-AB3C0F094F99Q53619865-5444975F-C840-4876-B663-2146E250630CQ54528863-29873037-B7AD-4F77-9F17-4FF8DD6B50AAQ55283293-9696C7EF-D3B0-4CC1-8C31-3696D1CD6342Q55617050-73C9C5AD-71C8-43CA-8F20-026223E1F9B3Q58824559-7B045969-9A7C-49AB-8547-01BC14DE8648
P2860
VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
VWF propeptide and ratios betw ...... type 1 von Willebrand disease.
@en
VWF propeptide and ratios betw ...... type 1 von Willebrand disease.
@nl
type
label
VWF propeptide and ratios betw ...... type 1 von Willebrand disease.
@en
VWF propeptide and ratios betw ...... type 1 von Willebrand disease.
@nl
prefLabel
VWF propeptide and ratios betw ...... type 1 von Willebrand disease.
@en
VWF propeptide and ratios betw ...... type 1 von Willebrand disease.
@nl
P2093
P2860
P50
P1433
P1476
VWF propeptide and ratios betw ...... type 1 von Willebrand disease.
@en
P2093
Augusto B Federici
Francesco Rodeghiero
Giancarlo Castaman
Jenny Goudemand
MCMDM-1VWD Study Group
Maria Teresa Canciani
Richard J Dirven
Ulrich Budde
P2860
P304
P356
10.1182/BLOOD-2012-09-455089
P407
P577
2013-01-24T00:00:00Z